The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety of everolimus for women over age 65 with advanced breast cancer (BC): 12.5-month follow-up of BOLERO-2.
Hope S. Rugo
Research Funding - Merck; Novartis; Pfizer
Howard A. Burris
No relevant relationships to disclose
Michael Gnant
Consultant or Advisory Role - Novartis
Honoraria - Amgen; AstraZeneca; Novartis; Roche; Sanofi
Research Funding - AstraZeneca; Novartis; Roche
José Baselga
Consultant or Advisory Role - Bayer; Chugai Pharma; Constellation; Exelixis; Merck Sharp & Dohme; Novartis; Onyx; Roche; Sanofi ; Verastem
Martine J. Piccart-Gebhart
Consultant or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Roche; Sanofi
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Roche
Research Funding - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Roche; Sanofi
Shinzaburo Noguchi
Consultant or Advisory Role - Novartis
Honoraria - AstraZeneca; Chugai Pharma; GlaxoSmithKline; Novartis; Pfizer; Sanofi ; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; GlaxoSmithKline; Novartis; Pfizer; Sanofi ; Takeda
Shaker R. Dakhil
No relevant relationships to disclose
Vichien Srimuninnimit
No relevant relationships to disclose
Puttisak Puttawibul
Research Funding - AstraZeneca; Novartis; Roche
Tibor Csoszi
No relevant relationships to disclose
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer
Hugues Bourgeois
No relevant relationships to disclose
Antonio Gonzalez-Martin
No relevant relationships to disclose
Karen Osborne
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Pabak Mukhopadhyay
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Tanya Taran
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Mario Campone
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Gabriel N. Hortobagyi
Consultant or Advisory Role - Allergan; Genentech; Novartis; Sanofi
Research Funding - Novartis
Other Remuneration - Genentech; Novartis; Sanofi
Tarek Sahmoud
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Kathleen I. Pritchard
Consultant or Advisory Role - Abraxis BioScience; Boehringer Ingelheim; Novartis; Pfizer; Roche
Honoraria - Abraxis BioScience; Boehringer Ingelheim; Novartis; Pfizer; Roche
Expert Testimony - AstraZeneca; Novartis